BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 22740449)

  • 1. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
    Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G
    Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.
    Dorrance AM; Liu S; Yuan W; Becknell B; Arnoczky KJ; Guimond M; Strout MP; Feng L; Nakamura T; Yu L; Rush LJ; Weinstein M; Leone G; Wu L; Ferketich A; Whitman SP; Marcucci G; Caligiuri MA
    J Clin Invest; 2006 Oct; 116(10):2707-16. PubMed ID: 16981007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
    Zorko NA; Bernot KM; Whitman SP; Siebenaler RF; Ahmed EH; Marcucci GG; Yanes DA; McConnell KK; Mao C; Kalu C; Zhang X; Jarjoura D; Dorrance AM; Heerema NA; Lee BH; Huang G; Marcucci G; Caligiuri MA
    Blood; 2012 Aug; 120(5):1130-6. PubMed ID: 22674806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele.
    Dorrance AM; Liu S; Chong A; Pulley B; Nemer D; Guimond M; Yuan W; Chang D; Whitman SP; Marcucci G; Caligiuri MA
    Blood; 2008 Sep; 112(6):2508-11. PubMed ID: 18617636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.
    Hayashi M; Kondoh K; Nakata Y; Kinoshita A; Mori T; Takahashi T; Sakamoto MI; Yamada T
    Br J Haematol; 2007 May; 137(3):221-32. PubMed ID: 17408461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults.
    Bäsecke J; Podleschny M; Clemens R; Schnittger S; Viereck V; Trümper L; Griesinger F
    Leuk Res; 2006 Sep; 30(9):1091-6. PubMed ID: 16540167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
    Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
    Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
    Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J
    Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
    Whitman SP; Liu S; Vukosavljevic T; Rush LJ; Yu L; Liu C; Klisovic MI; Maharry K; Guimond M; Strout MP; Becknell B; Dorrance A; Klisovic RB; Plass C; Bloomfield CD; Marcucci G; Caligiuri MA
    Blood; 2005 Jul; 106(1):345-52. PubMed ID: 15774615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MLL partial tandem duplication in acute myeloid leukaemia.
    Basecke J; Whelan JT; Griesinger F; Bertrand FE
    Br J Haematol; 2006 Nov; 135(4):438-49. PubMed ID: 16965385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).
    Sun QY; Ding LW; Tan KT; Chien W; Mayakonda A; Lin DC; Loh XY; Xiao JF; Meggendorfer M; Alpermann T; Garg M; Lim SL; Madan V; Hattori N; Nagata Y; Miyano S; Yeoh AE; Hou HA; Jiang YY; Takao S; Liu LZ; Tan SZ; Lill M; Hayashi M; Kinoshita A; Kantarjian HM; Kornblau SM; Ogawa S; Haferlach T; Yang H; Koeffler HP
    Leukemia; 2017 Jan; 31(1):1-10. PubMed ID: 27389053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia.
    Kong J; Zhao XS; Qin YZ; Zhu HH; Jia JS; Jiang Q; Wang J; Zhao T; Huang XJ; Jiang H
    Leuk Lymphoma; 2018 Apr; 59(4):967-972. PubMed ID: 28745571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene.
    Ommen HB; Hokland P; Haferlach T; Abildgaard L; Alpermann T; Haferlach C; Kern W; Schnittger S
    Br J Haematol; 2014 Jun; 165(5):618-28. PubMed ID: 24611505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.
    Bueno C; Ayllón V; Montes R; Navarro-Montero O; Ramos-Mejia V; Real PJ; Romero-Moya D; Araúzo-Bravo MJ; Menendez P
    Blood; 2013 May; 121(19):3867-78, S1-3. PubMed ID: 23479570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist-1, a novel regulator of hematopoietic stem cell self-renewal and myeloid lineage development.
    Dong CY; Liu XY; Wang N; Wang LN; Yang BX; Ren Q; Liang HY; Ma XT
    Stem Cells; 2014 Dec; 32(12):3173-82. PubMed ID: 25100001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
    So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
    Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
    Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
    Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disordered epigenetic regulation in MLL-related leukemia.
    Zhang Y; Chen A; Yan XM; Huang G
    Int J Hematol; 2012 Oct; 96(4):428-37. PubMed ID: 23054645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.